SPONSOR
Tianjin Medical University Cancer Institute and Hospital
Total Trials
2
Recruiting
2
Phases
Phase 2
Tianjin Medical University Cancer Institute and Hospital is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Pancreatic Cancer, Non-small-cell Lung Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Tianjin Medical University Cancer Institute and Hospital
How many clinical trials has Tianjin Medical University Cancer Institute and Hospital sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Tianjin Medical University Cancer Institute and Hospital, of which 2 are actively recruiting participants. These trials cover conditions including Pancreatic Cancer, Non-small-cell Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tianjin Medical University Cancer Institute and Hospital research focus on?
Tianjin Medical University Cancer Institute and Hospital clinical trials span Pancreatic Cancer, Non-small-cell Lung Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Tianjin Medical University Cancer Institute and Hospital clinical trial?
To participate in a Tianjin Medical University Cancer Institute and Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tianjin Medical University Cancer Institute and Hospital trials with current recruitment status updated daily.
Clinical Trials by Tianjin Medical University Cancer Institute and Hospital
NCT06404840 Phase 2
Recruiting
Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
Pancreatic Cancer
NCT06141226 Phase 2
Recruiting
Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer
Non-small-cell Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology